41 results
Posted on 28.06.2024
MedTech Europe Code: Trust is a priceless asset in healthcare
With new global challenges on the horizon, compliance with the MedTech Europe Code is an investment in the future If my years as a legal and compliance professional in Europe’s medical technology sector have taught me anything, it is the value of trust. It is vital that healthcare professionals and patients trust us to produce […]
Posted on 13.05.2024
Supporting the wellbeing of healthcare professionals is vital to patient outcomes and system sustainability
Healthcare professionals are under pressure. Stress and fatigue were a growing concern long before the pandemic put burnout under the spotlight. Now, amid a shortage of nurses and significant mental health issues among healthcare staff, governments, health systems and hospitals are facing a human resources crisis. The medical technology sector can play a constructive role […]
Posted on 25.01.2024
2024 European Elections: Take a stand for the Diabetes Community
Diabetes is a ‘silent pandemic’. If current trends continue, diabetes will soon be the number-one health threat in Europe. Political action is needed to improve the quality of prevention and care for patients and ensure the sustainability of healthcare systems, [highlighted in the Parliament Resolution of December 2023 on non-communicable diseases]. With European elections around the corner, the European […]
Posted on 27.04.2023
Join us in Dublin for The MedTech Forum 2023
More than 1,500 industry leaders will discuss the biggest issues facing our sector The countdown has begun. At the end of May, leading thinkers and decision-makers from across the medical technology sector will descend on the Irish capital city for Europe’s leading medtech industry event from 30 May to 1 June. Organised by MedTech Europe, […]
Posted on 14.07.2022
Addressing new expectations for the future of health
The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.
Posted on 28.04.2022
Time to prepare for the revolution in predictive genomics
Predictive genomics can transform healthcare, shifting the focus towards prevention and getting better value for the money we spend. In the first of a two-part mini-series, Francesco Floridini explores this new paradigm in healthcare. Healthcare today is all about treating people who are ill. They experience symptoms, engage with the health system, and receive an […]
Posted on 04.11.2021
Heart failure – the time to act is now
With Europe’s ageing population comes several social, economic and environmental benefits. It also brings rising risks of cardiovascular disease (CVD) which must be managed to protect citizens’ wellbeing and the sustainability of our health systems. That is why we are inspired to see 15 European and international health organisations joining forces to form the European […]
Posted on 17.03.2021
MedTech Slovenia: building the future together
The next chapter in the story of Slovenia’s medical technology industry has begun – and it is being co-written by leaders from the in-vitro diagnostics and medical devices sectors. SIEDMA and SLO-MED have formally merged to become MedTech Slovenia. Together, we are combining our expertise to speak for our diverse industry with one voice. […]
Posted on 22.05.2020
Closing the innovation loop: how start-ups can show value
One of my great frustrations is to see start-ups fall at the final hurdle. Too many early-stage companies with promising innovations spend their energy – and funds – answering crucial questions about the safety and effectiveness of their products, only to find that they have no answers to the additional questions asked by payers. […]